Select a year:
Select a category:

4P-PHARMA AT JPM Week 2022​

Revital Rattenbach, chairwoman of 4P-Pharma, will attend the J.P. Morgan Week 2022 in San Francisco, January 10th-12th, 2022. ​ ​Contact us via the partnering platform or by e-mail to schedule a meeting and discuss collaboration opportunities.​ ​For more information : https://events-export.businessfrance.fr/french-delegation-jp-morgan/​

Read More

4Living Biotech and Sanofi sign a clinical collaboration agreement

4Living Biotech and Sanofi signed a clinical collaboration agreement. The two companies will join their expertise to demonstrate the potential efficacy of Mozobil® as a treatment for acute and chronic complications of COVID-19. Pascal Rigaudy, Global Head, Transplant Brands at Sanofi, mentioned that “Through its collaboration with 4P-Pharma, Sanofi is delighted to continue to advance&hellip

Read More

4P-Pharma supports the GREMI webinar 2021

4P-Pharma supports the GREMI webinar “Inflammation: you get on my nerves” organized by the Groupe de Recherche et d’Etude des Médiateurs de l’Inflammation (GREMI), taking place on November 5th, 2021. The GREMI is a French-based association of academic and industrial scientists, dedicated to promote research on inflammation. For further info, click: here

Read More

4P-Pharma and Oncocross sign a research collaboration agreement

4P-Pharma and Oncocross, a Korea-based AI biotech,  signed a research collaboration agreement at the Institut Pasteur de Lille on October 25th, 2021. The two companies will join their expertise to bring an innovative therapeutic agent to the patients affected by Systemic Scleroderma, a rare autoimmune disease affecting the skin and internal organs that has no approved&hellip

Read More

4P-Pharma at 6th Drug Discovery Summit 2021

Revital Rattenbach,4P-Pharma’s chairwoman is attending the 6th Drug Discovery summit on November 3rd, 2021, as a key speaker. She will give a talk on “Fast-Development of a CXCR4 antagonist to fight against Covid-19 pandemic.” For further information, please feel free to contact us by e-mail , or click here.  

Read More